AVXL
400% better than Standard of Care:
Avanex 2-73 showed in 83 percent (10/12) of patients positive cognitive effects during PART A of the study, which consists of a 36-day on-off-on not-yet-optimized dosing regimen to assess bioavailability. At day 36, the amplitude of the cognitive EEG/ERP biomarker P300 increased 38 percent from baseline. Published data suggests that a 38 percent increase is approximately 4 times higher than donepezil (Aricept(R)), the current standard of care, in the same timeframe
400% better than Standard of Care:
Avanex 2-73 showed in 83 percent (10/12) of patients positive cognitive effects during PART A of the study, which consists of a 36-day on-off-on not-yet-optimized dosing regimen to assess bioavailability. At day 36, the amplitude of the cognitive EEG/ERP biomarker P300 increased 38 percent from baseline. Published data suggests that a 38 percent increase is approximately 4 times higher than donepezil (Aricept(R)), the current standard of care, in the same timeframe
2, Burn rate including trials only 500k/month, so 28 months of money available and more cash coming.
3. We intend to identify and initiate discussions with potential partners in the next 12 months, Who else wants to make at least 100% in a year?
4. The data demonstartes SIGNIFICANT improvement in the reduction of seizues to three GENERATIONS of epilepsy drugs currently on the market as well as significant synergy with each of thes drugs. Go alone or another partnership/buyout ! ( better results than GWPH )
5 Michael J Fox grant for parkinsons
6. Patent granted for major CNS diseases for lead drug
7. Lead drug focus on Alzheimers, Parkinsons, depression, MS, multiple cancers. Less
2, Burn rate including trials only 500k/month, so 28 months of money available and more cash coming.
3. We intend to identify and initiate discussions with potential partners in the next 12 months, Who else wants to make at least 100% in a year?
4. The data demonstartes SIGNIFICANT improvement in the reduction of seizues to three GENERATIONS of epilepsy drugs currently on the market as well as significant synergy with each of thes drugs. Go alone or another partnership/buyout ! ( better results than GWPH )
5 Michael J Fox grant for parkinsons
6. Patent granted for major CNS diseases for lead drug
7. Lead drug focus on Alzheimers, Parkinsons, depression, MS, multiple cancers. Less
I think that burn is going to ramp up as you know...so burn now at phase 1 and 2A is not burn at late 2 and into 3.
I think that burn is going to ramp up as you know...so burn now at phase 1 and 2A is not burn at late 2 and into 3.
Yeah solid moves JMC, but I kinda wonder if it just caught the general biotech move the last 3 days...
Yeah solid moves JMC, but I kinda wonder if it just caught the general biotech move the last 3 days...
The only risk you run doing that is if something really bad happens and it crashes through it..say like that data coming out in 3 weeks that you mentioned.
The only risk you run doing that is if something really bad happens and it crashes through it..say like that data coming out in 3 weeks that you mentioned.
Hot Forum Topics
- I'm embarrassed for Trump supporters 63,587
- Tuesday 11/10/2026 310
- NFL LOCKED IN! 113,699
- Florida Man Tuesday 3,317
- Week 11 Money 2,349
- BILLS/VIKS live in game comments welcome 797
- ::Tuesday:: 11/10 (34-15-0) +18.6 units 2,010
- 11/9 4,027
- Bags Tuesday LARGE **Michigan State vs Duke** 1,688
- MODERATE voters say ... 35,402
Warning - External Link
Report User
This post is spam
Delete Post
Remove Thread
Scan Results
Login/Register
Accounts are free and easy to create.
Search
